COMMUNIQUÉS West-GlobeNewswire

Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma
05/09/2018
Efficacy and safety continue to be a major advantage, with a very high response rate, no dose limiting toxicities and only a single incidence of suspected cytokine release syndrome P-BCMA-101 clinical data as well as [...]
HIFU Prostate Services Treats 1,000th Patient with HIFU, a Non-Invasive Prostate Cancer Treatment
05/09/2018
HIFU, or high intensity focused ultrasound, is a non-invasive, outpatient, radiation-free treatment for prostate cancer CHARLOTTE, N.C., Sept. 05, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC , the leading [...]
In-Depth Interview: Canadian Farming Royalty Enters The Cannabis Space While Leveraging A Wealth Of Agricultural Experience -- CFN Media
05/09/2018
SEATTLE, Sept. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Innovation Pharmaceuticals to Present Brilacidin for Inflammatory Bowel Disease at Inaugural “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis Foundation
05/09/2018
BEVERLY, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that the Company has been invited to present on the [...]
CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement
05/09/2018
CURE grants cannabis leader rights to its proprietary drug delivery technology in markets around the world LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), (“CURE”), an innovative drug [...]
CV Sciences, Inc. to Present and Exhibit as Gold Sponsor at Natural Products Expo East 2018 in Baltimore, Maryland, September 12-15, 2018
05/09/2018
Company enters its 3rd year sponsoring and exhibiting at the nation's second largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product [...]
CV's of the members of the Council of JSC Olainfarm, elected on 04th September, 2018
05/09/2018
Members of the Council of JSC Olainfarm, elected on 04 th September 2018 PĀVELS REBENOKS, Chairman of the Council Education: 2007 The University of Latvia. Master’s Degree in Law. 2003 Latvian Maritime Academy. [...]
Aura to Acquire Majority Interest in Israeli Cannabis Retailer in Partnership With Industry Icon Shlomi Sendak
05/09/2018
TORONTO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE: BUZZ ) is very pleased to announce it has entered into a binding term sheet (“ Term Sheet ” or “ Agreement ”) to acquire [...]
Ambu A/S: Major shareholder announcement
05/09/2018
In reference to § 30 and according to § 38 of the Danish Capital Markets Act (Kapitalmarkedsloven), Ambu hereby announces to have received a major shareholder announcement from Chr. Augustinus Fabrikker Akts. On 5 [...]
American College of Rheumatology Releases First-Ever Rheumatic Disease Report Card
05/09/2018
New Report Examines Access, Affordability and Lifestyle Factors Affecting Rheumatic Disease Care in all 50 States and the District of Columbia Atlanta, Sept. 05, 2018 (GLOBE NEWSWIRE) -- The American College of [...]
PSIQ Plans to Become a Fully Reporting SEC Issuer and Uplist to the OTCQB
05/09/2018
SUNRISE, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that Daszcal Bolton, LLP, an independent certified public accountant has completed the audit of PSIQ’s financial [...]
Zosano Pharma and Collaborators to Present Efficacy Data for M207 in the Treatment of Migraine at the 17th Biennial Migraine Trust International Symposium (MTIS)
05/09/2018
FREMONT, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference
05/09/2018
CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics ( TASE: ANCN ), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]
Bespoke Extracts Announces Launch of Wholesale CBD Division, Among Other Key Marketing and Business Developments
05/09/2018
SUNNY ISLES, Fla., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, today announced the launch of its newly formed Wholesale [...]
Diversicare Announces Appointment of Kerry D. Massey Executive Vice President and Chief Financial Officer
05/09/2018
BRENTWOOD, Tenn., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) today announced the appointment of Kerry D. Massey as the Company’s Executive Vice President and Chief Financial [...]
Evolus Appoints Ashwin K. Agarwal as Vice President, Finance, Investor Relations and Treasury
05/09/2018
IRVINE, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the appointment of Ashwin K. Agarwal as Vice President, Finance, Investor [...]
Matinas BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
05/09/2018
Presentation with live audio webcast on Thursday, September 6th at 5:05 PM ET BEDMINSTER, N.J., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical [...]
Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
05/09/2018
LAKE FOREST, Ill., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that members of senior [...]
AIT Therapeutics Announces $526,500 Sale of Common Stock To Institutional Investor, Lincoln Park Capital Fund
05/09/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 05, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB:AITB) (“AIT Therapeutics or the “Company”), a clinical-stage medical device and biopharmaceutical company focused [...]

Pages